Stay updated on Zephyrus I Clinical Trial
Sign up to get notified when there's something new on the Zephyrus I Clinical Trial page.

Latest updates to the Zephyrus I Clinical Trial page
- Check5 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.0%
- Check12 days agoChange DetectedThe web page has been updated to reflect the upcoming modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an updated version number from v2.16.0 to v2.16.1.SummaryDifference0.8%
- Check19 days agoChange DetectedThe web page has been updated to version 2.16.0, replacing the previous version 2.15.2.SummaryDifference0.1%
- Check27 days agoNo Change Detected
- Check48 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.0%
- Check55 days agoChange DetectedThe page has undergone significant content removal, particularly regarding the details of a Phase 3 trial for pamrevlumab in treating Idiopathic Pulmonary Fibrosis (IPF), including key inclusion and exclusion criteria. The revision number has been updated from v2.14.4 to v2.15.0.SummaryDifference17%
- Check70 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.0%
Stay in the know with updates to Zephyrus I Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Zephyrus I Clinical Trial page.